Olio Labs Launches High-Throughput In Vivo Platform for Predicting Clinical Outcomes
BenSiranosian · x · 2026-08-06
Olio Labs has announced its new in vivo platform, designed to bring predictive validity to the most unpredictable stages of drug discovery. The platform aims to predict diverse human clinical outcomes from a single high-throughput experiment.
By streamlining the validation process, this technology could significantly reduce the time and uncertainty associated with traditional drug discovery pipelines, marking a notable advancement in AI-driven life sciences.
Related event: Olio Labs Launches High-Throughput In Vivo Prediction Platform(2 posts)→
More from Apps
- Plane AI Translates Natural Language Directly into PQL Queries — JosephJacks_ · 2026-08-06
- Researcher Builds a 'Second Brain' for Lab Using Claude and Adapter — Prof_DavidBader · 2026-08-06
- Gradio x Modal Hackathon Winners: Browser AI Dueling Game Takes First Place — Gradio · 2026-08-06
- YC-Backed Context.dev Launches API to Turn the Live Web into Structured Data for AI Agents — ycombinator · 2026-08-06
- Cambrian API Launches Publicly: Providing Onchain/Offchain Signals for Financial AI Agents — Scobleizer · 2026-08-06
- Chat is a Bad Interface for AI Agents: Build Custom Interactions Instead — DanWahlin · 2026-08-06